A short history of anti-rheumatic therapy. I. An introduction on traditional and drug treatments

被引:1
|
作者
Pasero, G. [1 ]
Marson, P. [2 ]
机构
[1] Univ Pisa, Pisa, Italy
[2] Univ Padua, Azienda Osped, UOC Immunotrasfus, Unita Aferesi Terapeut, Padua, Italy
关键词
History of medicine; rheumatology; traditional treatments; drugs; spa therapy; physical therapy;
D O I
10.4081/reumatismo.2010.76
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The origins of anti-rheumatic therapy are very old and mainly related to the use of traditional, sometimes extravagant, treatments, as a part of folk medicine. Spa therapy has long been used for the treatment of rheumatic diseases, as well as, in later times, physical treatments, including electrotherapy. Drug treatment has developed beginning from substances of vegetable origin, such as willow and colchicum extracts. Then it has been spread out through the chemical synthesis of compounds with specific action and therefore more effective, owing to the great development of pharmaceutical industry.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 50 条
  • [21] Time to first disease modifying anti-rheumatic drug therapy (DMARD) among rheumatic disease patients in a population based study.
    Johannes, CB
    Schneider, G
    Aygun, AC
    L'Italien, GJ
    Viveash, D
    Wallis, WJ
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S337 - S337
  • [22] Gene expression of Interleukin-18 in rheumatoid arthritis patients on disease modifying anti-rheumatic drug therapy
    Khalid, Sabeen
    Yousaf, Muhammad Javad
    Rashid, Amir
    Khan, Saleem Ahmad
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2019, 35 (03) : 802 - 806
  • [23] Disease Modifying Anti-rheumatic Drug and Biologic Therapy in Pregnancy: A Single-center Mixed Methods Study
    Glick, Lauren
    Shamis, Justin
    McGhie, Taneisha
    Mahendira, Dharini
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] SAFETY AND RETENTION OF TRIPLE CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN EARLY RHEUMATOID ARTHRITIS
    Katikireddi, V
    Shankaranarayana, S.
    Cummins, L.
    Pahau, H.
    Duggan, E.
    Thomas, R.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 27 - 28
  • [25] Persistence on Single Disease Modifying Anti-Rheumatic Drug Therapy in US Veterans with Rheumatoid Arthritis Is Extremely Rare
    Kruger, Jonathan
    Morgan, Michael
    Reimold, Andreas
    Mikuls, Ted R.
    Kerr, Gail
    Cannon, Grant W.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1089 - S1090
  • [26] An audit of disease modifying anti-rheumatic drug (DMARD) therapy use in rheumatoid arthritis patients at a district general hospital
    King, Jonathan
    Mewinska, M.
    O'Rourke, Killian
    Laversuch, Catherine
    Cook, Lorraine
    Jewell, Theresa
    RHEUMATOLOGY, 2008, 47 : II138 - II138
  • [27] IMPACT OF MULTIMORBIDITY ON DISEASE MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN EARLY RHEUMATOID ARTHRITIS: DATA FROM THE ESPOIR COHORT
    Beltai, A.
    Combe, B.
    Coffy, A.
    Gaujoux-Viala, C.
    Lukas, C.
    Saraux, A.
    Dougados, M.
    Daures, J. P.
    Hua, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 379 - 379
  • [28] AFPL-50. Rheumatoid arthritis (RA) and disease modifying anti-rheumatic drug (DMARD) therapy: The Glasgow approach'
    McEntegart, A.
    McIvor, E. M.
    CLINICAL RHEUMATOLOGY, 2007, 26 (04) : 646 - 646
  • [29] Persistence On Single Disease Modifying Anti-Rheumatic Drug Therapy In US Veterans With Rheumatoid Arthritis Is Extremely Rare.
    Kruger, Jonathan
    Mikuls, Ted R.
    Cannon, Grant W.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S602 - S603
  • [30] BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
    Chakravarty, K.
    McDonald, H.
    Pullar, T.
    Taggart, A.
    Chalmers, R.
    Oliver, S.
    Mooney, J.
    Somerville, M.
    Bosworth, A.
    Kennedy, T.
    RHEUMATOLOGY, 2008, 47 (06) : 924 - 925